The Chemotherapy Cornerstone: Understanding the Doxorubicin Market
The Doxorubicin Market is a vital and enduring segment of the global oncology pharmaceutical industry, providing a cornerstone chemotherapeutic agent for the treatment of various cancers. Doxorubicin is an anthracycline antibiotic that works by intercalating DNA and inhibiting topoisomerase II, thereby preventing cancer cell division. Currently valued at approximately USD 2.4 billion in 2024,...
0 Comments 0 Shares 68 Views 0 Reviews